Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 383.40%. However, over the last six months, the performance has been weaker by 128.34%. The price of NAGE increased 18.39% over the last 30 days. And in the last five days, it has fallen by -9.34%.
Niagen Bioscience Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $14.69 on 06/30/25, and the lowest price during that time was $2.40, recorded on 07/08/24.
52-week price history of NAGE Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Niagen Bioscience Inc’s current trading price is -12.80% away from its 52-week high, while its distance from the 52-week low is 432.64%. The stock’s price range for this period has been between $2.40 and $14.69. The Healthcare sector company’s shares saw a trading volume of about 1.76 million for the day, which was higher than the average daily volume of 0.92 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Niagen Bioscience Inc (NAGE) has experienced a quarterly rise of 85.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.01B and boasts a workforce of 104 employees.
How Moving Averages and Trading Volume Data Work Together
NAGE’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for NAGE stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.05.
